HealthActemra Achieves Positive Trial Results As Giant Cell Arteritis Treatment, Receives Priority Review Designation From FDA Actemra achieved positive results at the end of the Phase III trial, and its Supplemental Biologics License Application was accepted by the FDA. The medication is employed in treating patients who suffer from giant cell arteritis.by Livia Rusu
HealthUS Cervical Cancer Death Rate Higher Than Thought: Here’s How Women Can Lower Their Cervical Cancer Riskby Livia Rusu
HealthSitting Too Much Makes Women Age Faster: Counter Accelerated Aging With These 5 Tipsby Arrianne Del Rosario
HealthFake News 'Vaccine' May Help Provide Immunity Against Misinformation Spreading On Facebookby Allan Adamson